Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Terminated
Checked: April 17, 2026 at 5:01 AM UTC
| NCT Number | NCT06685068 |
| Recruiting Status | Terminated |
| Condition | Advanced Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 260 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Genmab |
| Last Updated on CT.gov | April 14, 2026 (3 days ago) |
As of April 17, 2026: Clinical trial NCT06685068 is currently terminated participants. This clinical trial study for advanced solid tumors is not currently accepting new participants at 3 locations across the United States. The study is sponsored by Genmab. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06685068 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06685068 was last updated 3 days ago (April 14, 2026). HelloStudys verifies this status automatically.